The strong association between epithelial HSP regulation and the concurrent probiotic effects against detrimental factors observed in this study provides novel insights into the natural defense mechanisms of gut epithelial cells and may open new avenues for IBD treatments. The gene discussed is HSP90B2P; the disease is inflammatory bowel disease.